CERN Accelerating science

NEWS!

• 26/09/2022

The half-life of Tb-155 produced at MEDICIS has been revised and is now published by S. Collins et al. in Applied Radiation and Isotope. High molar activity Sm-153 was 1st used in Targeted Radionuclide Therapy and theranostics (MED-025) by M. Ooms et al, as presented at TERACHEM.

• 06/09/2022

A third collaboration meeting took place today in the French ANR project REPARE, to review the progresses on the development of a high power Bi target for the production of At-211.

• 15/06/2022

1st projects have been selected in PRISMAP-The European medical isotope programme.

• 27/05/2022

Plenary presentation on new developments exploiting isotope mass separation in nuclear medicine presented at the 1st AccConf'22 at IAEA.

• 02/05/2022

MEDICIS restarts its program today. Mass separation will be applied to purify and separate Sm-153 from a target produced at BR2. Some details on the project here.

• 04/02/2022

World cancer day: webinar at 11:30 on MEDICIS mass separation and its impact on theranostics here.

• 29/11/2021

The 1st call for user projects of PRISMAP is launched! More information here.

• 23/09/2021

PRISMAP-The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. More information here.

JOB OPPORTUNITIES

• Opening for  a postdoc position at TRIUMF with a focus on mercury-197 radiochemistry and chelation. More details on https://triumf.wd10.myworkdayjobs.com/en-US/careers-at-triumf-job-posti…, post JR100262